STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
STERIS plc
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$221.97−0.69 (-0.31%)
Close on Oct 19, 2026
- Market cap
- $21.73B
- P/E (TTM)
- 27.1
- Dividend yield
- 1.11%
STERIS plc revenue by segment
By business segment
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare | $4.28B | $4.21B | $4.13B | $4.04B | $3.95B | $3.88B | – | – | – | – | – | – | 70.9% | +8.3% |
| Applied Sterilization Technologies | $1.15B | $1.14B | $1.12B | $1.09B | $1.07B | $1.04B | $1.02B | $992.35M | $970.70M | $954.00M | $942.23M | $929.31M | 19.1% | +7.9% |
| Life Sciences | – | – | – | – | $549.02M | $542.30M | $553.45M | $563.64M | $568.79M | $571.70M | $568.53M | $543.24M | – | – |
By product or service
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $3.11B | $3.06B | $3.02B | $2.96B | $2.91B | $2.87B | $2.86B | $2.85B | $2.81B | $2.76B | $2.36B | $2.33B | 51.5% | +6.9% |
| Service [Member] | $2.93B | $2.88B | $2.81B | $2.75B | $2.67B | $2.59B | $2.54B | $2.48B | $2.43B | $2.37B | $2.32B | $2.27B | 48.5% | +10.0% |
By region
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $4.40B | $4.33B | $4.27B | $4.18B | $4.09B | $4.01B | $3.97B | $3.91B | $3.84B | $3.75B | $3.38B | $3.31B | 72.9% | +7.6% |
| Ireland | $114.90M | $108.50M | $114.70M | $112.10M | $107.60M | $107.30M | $91.76M | $87.26M | $84.86M | $82.70M | $81.20M | $79.56M | 1.9% | +6.8% |
| Other foreign locations | – | – | – | $1.41B | $1.38B | $1.34B | $1.34B | $1.33B | $1.31B | $1.30B | $1.22B | $1.21B | – | – |
From the segment and revenue-disaggregation notes of Steris's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.